Andere Sprachen REGENXBIO Inc.

Aktien

A140E0

US75901B1070

RGNX

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 12.06.2024			% 5 Tage	% 1. Jan.
13,15 ^USD	-3,17 %		-8,17 %	-26,74 %

12.06.	Regenxbio ernennt Curran Simpson zum Präsidenten und CEO	MT
12.06.	Transcript : REGENXBIO Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:00 AM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Regenxbio Names Curran Simpson President, CEO	12.06.
REGENXBIO to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	05.06.
Diabetic Retinopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	15.05.
REGENXBIO to Participate in Upcoming Investor Conferences	13.05.
REGENXBIO to Participate in Upcoming Investor Conferences	10.05.
Regenxbio: Q1 Earnings Snapshot	08.05.
Earnings Flash (RGNX) REGENXBIO Posts Q1 Revenue $15.6M	08.05.
REGENXBIO Inc. Announces Consolidated Impairment Charges for the First Quarter Ended March 31, 2024	08.05.
REGENXBIO Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
REGENXBIO to Host Conference Call on May 8 to Discuss First Quarter 2024 Financial Results and Recent Operational Highlights	01.05.
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	24.04.
REGENXBIO And Sarepta Agree To Stay Litigation Pending Outcome Of Sarepta's IPR Petition	04.04.
One-time gene therapy could improve wet AMD	01.04.
REGENXBIO Inc. Announces Lancet Publication of Phase I/IIa Study Evaluating ABBV-RGX-314 as a One-Time Gene Therapy for Wet AMD	28.03.
REGENXBIO to Participate in Cantor Fitzgerald's Virtual DMD and Other Dystrophy Days	27.03.
REGENXBIO to Participate in Upcoming Investor Conferences	11.03.
North American Morning Briefing : Stock Futures -2-	11.03.
Regenxbio Insider Sold Shares Worth $365,220, According to a Recent SEC Filing	08.03.
REGENXBIO Announces Proposed Public Offering of Common Stock	07.03.
North American Morning Briefing : Powell Still in -2-	07.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen REGENXBIO Inc.

Aktien

A140E0

US75901B1070

RGNX

Andere Sprachen

Filter